Condition

Diabetes Mellitus Type 1

ClinicalTrials.gov condition label

Clinical trials54

Recruiting6

Common interventions25

Lead sponsors shown15

Clinical trials

54 shown

HOME-AHCL: Home-Based Implementation of an Advanced Hybrid Closed-Loop System With Telemonitoring in Type 1 DiabetesNCT07492992 · 2026-04-22

Changes in Person-reported Outcomes and Behavior Using the Accu-Chek SmartGuide CGM and Predict AppNCT07814508 · 2026-02-01

CBTi for the Treatment of Insomnia in Type 1 DiabetesNCT07091318 · 2025-12-01

Efficacy and Safety of the APGO Algorithm for Automated Insulin DeliveryNCT07320495 · 2025-06-19

Type 1 Diabetes and Diabetes DistressNCT06936280 · 2025-04-01

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney DiseaseNCT06217302 · 2024-10-31

The Effect of Light Therapy on Cellular Energy and Oxidative Stress in Healthy Adults and Type 1 Diabetic PatientsNCT07833865 · 2026-10-01

NOT_YET_RECRUITING

A Study of the Safety and Efficacy of Pancreatic Endocrine Cell Clusters Implanted Into the Omentum of Type 1 Diabetes Patients With Severe HypoglycemiaNCT06651515 · 2025-04-01

SMARTCLOTH. Design, Implementation and Study of the Effectiveness and Usability of a Digital Tablecloth for Self-management of Diet in Diabetic Patients.NCT06623708 · 2024-10-01

Real-life Follow-up of the Physical Activity in Type 1 Diabetes Participants Equipped With an Insulin Pump With Hybrid Closed LoopNCT07015970 · 2024-03-05

FinnDiane LifeOne Study - Impact of Ageing on People With Type 1 DiabetesNCT07289204 · 2024-01-29

ENROLLING_BY_INVITATION

Feasibility of Non-invasive Glucose Monitoring by Using Photothermal DeflectometryNCT06088615 · 2023-11-08

Psychiatric Disorders Related to Diabetes Mellitus Type 1NCT05477433 · 2022-08-01

Psychiatric Disorders Related to Diabetes Mellitus Type 1 Among Children in EgyptNCT05477173 · 2022-08-01

A Pilot Study of the Therapeutic Potential of Stem Cell Educator Therapy in Type 1 DiabetesNCT02624804 · 2017-06-27

Clinical Trial Assessing the GNbAC1 in Patients With Onset of Type 1 Diabetes Within 4 YearsNCT03179423 · 2017-06-14

Use of Stem Cells in Diabetes Mellitus Type 1NCT02940418 · 2017-02-19

ZP4207(Dasiglucagon) Administered to T1D Patients to Assess the PK and PD Compared to Marketed GlucagonNCT02916251 · 2016-12-01

Gastric Ultrasound of Diabetic and Non-Diabetic Patients Following Preoperative Fasting InstructionsNCT02888951 · 2016-08-01

Continuous Glucose Monitoring During Intecorse in Young Adults With Type 1 DiabetesNCT02750111 · 2016-05-01

The iLet Introduction Study: A Feasibility Study of the iLet, a Fully Integrated Bihormonal Bionic PancreasNCT02701257 · 2016-03-01

Long Term CGM Treatment in Patients With Type 1 Diabetes Treated With Insulin InjectionsNCT02465411 · 2015-06-01

Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections to Reach HbA1c Targets in Children and Adolescents With Type 1 DiabetesNCT02403375 · 2015-05-17

Blood Glucose Control With BioChaperone Insulin Lispro Compared to Insulin Lispro (Humalog®) After Ingestion of a Standardized MealNCT02344992 · 2015-01-01

A Double-blinded, Randomised, Three-period Crossover Euglycaemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Human Insulin, Human Insulin (Huminsulin® Normal) and Insulin Lispro (Humalog®) in Subjects With Type 1 DiabetesNCT02213146 · 2014-08-01

A Study of Intracellular Signaling in Muscle and Fat Cells During KetosisNCT02157155 · 2014-06-01

A Double-blinded, Randomised, Four-period Crossover Euglycemic Clamp Trial Investigating the Dose-response and Dose-exposure Relationship of BioChaperone Insulin Lispro in Three Different Doses in Subjects With Type 1 DiabetesNCT02146651 · 2014-05-01

MoCa Test for the Early Detection of Mild Cognitive Impairment During Annual Assessment of Young Adults With Diabetes and in a Control Group Without DiabetesNCT02545062 · 2014-05-01

A Multicenter Study of Outpatient Automated Blood Glucose Control With a Bihormonal Bionic PancreasNCT02092220 · 2014-04-01

Effect of Microvesicles and Exosomes Therapy on β-cell Mass in Type I Diabetes Mellitus (T1DM)NCT02138331 · 2014-04-01

A Prospective, Randomized, Double-blind, Placebo Controlled Study to Assess the Impact of ORMD-0801 (Insulin Capsules) on the Exogenous Insulin Requirements of Type 1 DiabeticsNCT02094534 · 2014-03-01

Transplantation of Autologous Stem Cells for the Treatment of Type 1 Diabetes MellitusNCT02644759 · 2014-02-01

A Double-blinded, Randomised, Two -Period Crossover Euglycemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Insulin Lispro and Insulin Lispro (Humalog®) in Subjects With Type 1 DiabetesNCT02029924 · 2013-12-01

Effects of Exercise and Inhibition of Dipeptidyl Peptidase-4 on Insulin Secretion in Subjects With Type 1 DiabetesNCT02127047 · 2013-11-01

Trial to Compare the Relative Pharmacodynamic Properties of Different Glucagon DosagesNCT01916265 · 2013-08-01

Diameter Changes of Retinal Vessels During HypoxiaNCT01689090 · 2012-11-01

Mixed Meal Test in Type 1 Diabetes: Optimization of Artificial Pancreas-Pilot StudyNCT01800734 · 2012-10-01

Measuring and Monitoring Blood Glucose Levels Utilizing Non-invasive Blood Glucose Monitoring DeviceNCT01508065 · 2012-09-01

Assessment of the Neurovascular Microcirculatory Response in Diabetes Type 1 PatientsNCT02538120 · 2012-05-01

The Influence of Partial Remission Phase of Type 1 Diabetes on Patient OutcomeNCT02220257 · 2012-01-01

Pharmacokinetic and Pharmacodynamic Properties of BIOD-105 and BIOD-107 Compared to Humalog® in Subjects With Type 1 DiabetesNCT01334151 · 2011-03-01

The Effect of Supplementation With Two Different Doses of Vitamin D on Bone Mineral Density, Vitamin D Levels and Hand Grip Strength in Children With Diabetes Mellitus Type 1NCT01277913 · 2011-01-01

A Study of the Rules for Insulin Dosing in Patients Using Multiple Daily InjectionsNCT01045954 · 2010-01-01

Effects of XOMA 052 on Insulin Production in Type 1 DiabetesNCT01788033 · 2009-09-01

Comparison of the Management of Post-prandial Hyperglycemia by Multiple Bolus CalculatorsNCT01050868 · 2009-06-01

Natural History of Autoimmune Diabetes and Its ComplicationsNCT00896610 · 2009-05-13

Novel Therapy to Preserve Beta Cell Function in New Onset Type 1 DiabetesNCT00837759 · 2009-02-01

Assessment of the Effects of a DPP-4 Inhibitor (Sitagliptin) Januvia on Immune Function in Healthy IndividualsNCT00813228 · 2009-01-06

A Monocenter, Open-Label Glucose Clamp Study Examining the Metabolic Effect of Insulin Infusion Intervals for Basal Insulin Infusion in Patients With Type I DiabetesNCT00772356 · 2008-01-01

Comparison of Basal (Fasting) Glycemic Control in Type 1 Diabetic Patients With CSII Achieved by the Circadian Slide Ruler Scale or Flat Basal RateNCT00569452 · 2006-01-01

Basal Analog Study - Comparison of Lantus or Levemir With NPH Insulin From T1DM DiagnosisNCT01271517 · 2005-09-01

A Study Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections With Insulin Lispro and GlargineNCT00468754 · 2003-07-01

Glulisine Pre- and PostmealNCT00290043 · 2001-12-01

Solitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing ImmunosuppressionNCT00006505 · 2000-11-16

Common interventions

Leading sponsors

Hoffmann-La Roche5 Adocia4 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)4 Assiut University2 Massachusetts General Hospital2 University of Aarhus2 Air Liquide Healthcare Spain1 Alessandro Doria1 Azienda Ospedaliera Universitaria Integrata Verona1 Biodel1 Charles University, Czech Republic1 Clalit Health Services1 Diabetes Care Center1 Diamontech AG1 Dr. Orit Hamiel1

Trial status mix

COMPLETED29

UNKNOWN13

RECRUITING6

TERMINATED3

ENROLLING_BY_INVITATION1

NOT_YET_RECRUITING1

WITHDRAWN1

Phase mix

NA18

PHASE212

PHASE111

PHASE43

PHASE32

EARLY_PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.